Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment

Yano, S.
December 2002
Thorax;Dec2002, Vol. 57 Issue 12, p1085
Academic Journal
Pulmonary lymphangloleiomyomatosis (LAM) is a rare disease that affects women in the reproductive years. It is occasionally associated with tuberous sclerosis, especially in the incomplete form. As it is likely that oestrogen plays a central role in disease progression, exogenous oestrogen will cause a deterioration in LAM. However, the early stage of this disease is easy to miss unless the physician is a specialist. Although there have been some reports in menopausal women given exogenous oestrogen for osteoporosis, this is the first report of pulmonary LAM caused by exogenous oestrogen used for the treatment of infertility.


Related Articles

  • Lymphangioleiomyomatosis (LAM) as a surgical emergency. Caushi, Fatmir; Hafizi, Hasan; Gkinos, Elton Evangelos; Cuko, Armela; Thomaj, Arian; Menzelxhiu, Agron; Hatibi, Alban; Nuredini, Ornela // Pneumon;Jul-Sep2012, Vol. 25 Issue 3, p310 

    Photographs of the results of the computed tomography (CT) of a 52-year-old woman with lymphangioleiomyomatosis (LAM) are presented.

  • Localized Retroperitoneal Lymphangioleiomyomatosis Mimicking Malignancy. Jaiswal, Vilkesh R.; Baird, Julie; Fleming, Jason; Miller, David Scott; Sharma, Suash; Molberg, Kyle // Archives of Pathology & Laboratory Medicine;Jul2003, Vol. 127 Issue 7, p879 

    Lymphangioleiomyomatosis (lymphangiomyomatosis [LAM]), a rare disease of unknown etiology that is seen only in women usually in the reproductive period, generally presents with features of pulmonary involvement. Extrapulmonary involvement, such as angiomyolipomas and retroperitoneal adenopathy,...

  • Diffuse neonatal abdominal lymphangiomatosis: management by limited surgical excision and sclerotherapy. Güvenç, B. Haluk; Ekingen, Gülşen; Tuzlacı, Ayşe; Şenel, Ufuk; Güvenç, B Haluk; Ekingen, Gülşen; Tuzlaci, Ayşe; Senel, Ufuk // Pediatric Surgery International;Jul2005, Vol. 21 Issue 7, p595 

    Complete excision of diffuse abdominal lymphangiomatosis in the newborn is next to impossible. A 3-day-old female infant was found to have diffuse abdominal lymphangiomatosis predominantly in the left mesocolon and retroperitoneum. Initial management was by marsupialization, which was...

  • Lymphangioleiomyomatosis - presence of receptor tyrosine kinases and the angiogenesis factor as potential therapeutic targets. Magnussen, Helgo; Waiz, Henrik; Engels, Knut; Loeschke, Siegfried; Amthor, Michael; Kirsten, Deflef // Thorax;Jun2007, Vol. 62 Issue 6, p559 

    The article discusses an immunochemistry study to express proteins in lymphangioleiomyomatosis (LAM) cells in the presence of tyrosine kinases. The assessment of the LAM histological score and the immunohistochemic al stainings were performed by histopathologists . There were no amplification or...

  • Lymphangioleiomyomatosis -- A Brief Review and Estimation of Excess Risk. Sinhyung Lee // Journal of Insurance Medicine;2012, Vol. 43 Issue 1, p27 

    Lymphangioleiomyomatosis (LAM) is a rare pulmonary disease in women of child-bearing age. It is multisystem disease and affects mainly the lungs. A recently published Korean medical article showed a sharp increase of LAM patients in Korea since 2004. LAM is not discussed in the standard textbook...

  • Limfangiolejomiomatoza pluća (LAM). Čukić, Vesna; Lovre, Vladimir; Bešlić, Šerif; Bilalović, Nurija; Guska, Safet // Medicinski Arhiv;2008, Vol. 62 Issue 3, p180 

    Lymphangioleiomyomatosis (LAM) is extreme rare diffuse lung disease of unknown cause seen almost exclusively in women of child-bearing age and rarely postmenopausal which indicates the involvement of hormones-estrogens. It results from proliferation of the cells having a smooth muscle cell...

  • Massive Progression of Diffuse Hepatic Lymphangiomatosis After Liver Resection and Rapid Deterioration After Liver Transplantation. Datz, Christian; Graziadei, Ivo W.; Dietze, Otto; Jaschke, Werner; Königsrainer, Alfred; Sandhofer, Friedrich; Margreiter, Raimund // American Journal of Gastroenterology;Apr2001, Vol. 96 Issue 4, p1278 

    Hepatic involvement is an exceptional presentation of lymphangiomatosis. In this case report we describe a patient who underwent liver transplantation secondary to progressive hepatic involvement, which occurred 2 yr after partial hepatectomy. Within 1 yr after liver transplantation the disease...

  • Sirolimus Treatment for Pulmonary Lymphangioleiomyomatosis. Taillé, Camille; Debray, Marie-Pierre; Crestani, Bruno // Annals of Internal Medicine;5/1/2007, Vol. 146 Issue 9, p687 

    The article presents a study of a 34-year-old black female nonsmoker who was diagnosed of sporadic pulmonary lymphangioleiomyomatosis (LAM). The study aims to explore whether sirolimus could provide clinical benefit for the patient. In October 2005, the patient was administered with sirolimus....

  • Extrapulmonary lymphangioleiomyomatosis in pelvic lymphadenectomy associated with invasive endometrial carcinoma. Ruiz-Molina, Inmaculada; Cívico-Amat, Vicente; Solís-García, Eduardo // Revista Española de Patología;jul-sep2014, Vol. 47 Issue 3, p193 

    Lymphangioleiomyomatosis (LAM) is a rare disease occurring mostly in young women of childbearing age. This condition leads to a progressive cystic destruction of lungs due to the accumulation of epithelioid smooth muscle cells (LAM cells) in parenchymal and lymph nodes. LAM presents as a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics